Jurnal 2
Jurnal 2
Jurnal 2
VIKAS KUMAR
2
Chitkara School of Pharmaceutical Sciences, Chitkara University, Himachal Pradesh
*Corresponding author
ABSTRACT
A simple and sensitive spectrophotometric method was developed and validated for the
determination of Theophylline (TH) in pharmaceutical dosage form as well as in human
saliva and urine samples. This method is based on the measurement of absorbance of TH
in Phosphate Buffer 6.8 at 270 nm. Beer’s law is obeyed over the range of 2-10 µg/ml. This
method was used successfully for the quality assessment of Theophylline drug in human
urine and saliva samples with good precision and accuracy. The Sandell sensitivity, limit of
detection (LOD) and limit quantification (LOQ) values are also reported. All the methods
were validated in accordance with current ICH guidelines. The developed methods were
employed with high degree of precision and accuracy for the estimation of total drug
content in commercial tablet formulations of TH. The results obtained from human spiked
urine and saliva are satisfactory and recovery values were in limits.
INTRODUCTION
Systemic drugs administered orally or spectrophotometry. These methods require long
parenterally must reach the general circulation in and tedious pretreatment of the samples and
their pharmacologically active form to be laborious clean up procedures prior to analysis.
distributed throughout the body and to exert Therefore, it is very imperative to develop a
therapeutic effect. The intensity of the simple and suitable analytical method for the
therapeutic actions of many drugs correlate well determination of theophylline in saliva and urine.
with the concentration of the drug in the UV-Visible spectrophotometry is the technique of
biological fluid, Koch-weser et al (1982). The rate choice in research laboratories, hospitals and
of absorption is therapeutically important with pharmaceutical industries due to its low cost and
single doses of drugs, especially in case of inherent simplicity, Rajinder et al (2009).
narrow therapeutic index drugs, Benet et al
(1995). where relatively small changes in the Experimental Procedure
concentration can lead to marked changes in
pharmacodynamic response. Theophylline is a Materials
narrow therapeutic index drug and exhibits dose- Pure Theophylline was obtained as a gift sample
dependent pharmacokinetics, Dahlquist et al from Cipla Ltd. TH-1, TH-2 are Phylobid &
(1984). It is commonly used for the control and Theobid 200mg respectively. All the chemicals
management of acute asthma and acute were used of analytical grade. All Absorbance
exacerbations of chronic obstructive lung measurements were made on Shimadzu model
disease, Markham et al (1998). UV 1601 double beam UV Visible
The determination in biological fluids normally spectrophotometer with matched quartz
requires the use of trace analysis techniques cuvettes.
such as HPLC, LC, capillary electrophoresis
(CE), cyclic voltametry, LC-MS, gas Method
chromatography– mass spectrophotometry (GC- Calibration curve of Theophylline:
MS), inductively coupled plasma – mass
Fig - 1
Calibration curve of TH in phosphate buffer pH 6.8
Table 1
Summary of optical and regression characteristics of the proposed method
Parameters Theophlline
Linear dynamic range (µg/ml) 2-20
Regression equation Y=4.5x10-2+0.157
Correlation coefficient (r) 0.998
LOD (µg/ml) 2.17x10-1
LOQ (µg/ml) 7.895x10-2
Estimation of drug in urine and saliva point of time are given in (Table.2). The plots
The proposed methods were found to be of average % cumulative of TH excreted over
simple, accurate and reproducible for routine a period of 12 h versus mid-point of time and
estimation of TH in urine and saliva. The average (log(dAU/dt )) versus mid-point of
average values for % cumulative amount of time, are shown in (Fig. 1& Fig. 2)
TH excreted, rate of excretion (dAU/dt ) and respectively. From these figures it is evident
log-transformed rate of excretion (log(dAU/dt that analysis of TH can be done for a period of
)) for both urine and saliva with respect to mid- 12 hrs in urine and saliva respectively.
Fig.1
Average % cumulative TH excreted, versus mid-point of time plots after administration to
eight healthy male volunteers
Fig 2
Average log excretion rate (log (dAU/dt )) versus mid-point of time plots for TH after
administration to eight healthy male volunteers in urine and saliva
REFERENCES
1. Benet LZ, Goyan JE., Bioequivalence and 9. Rajinder Singh Gujral, Sk Manirul Haque,
narrow therapeutic index drugs. Prem Shanker., A Sensitive
Pharmacotherapy, 15:433-40, (1995). Spectrophotometric Method for the
2. Dahlquist R, Billing B, Miners JO, Birkett DJ., Determination of Pregabalin in Bulk,
Nonlinear metabolic disposition of Pharmaceutical Formulations and in Human
theophylline. Ther Drug Monit., 6:290-7, Urine Samples. Int J Biomed Sci., 5:421-428,
(1984). (2009).
3. Gujral RS, Haque SM, Kumar S., African J. 10. Sharma A, Dr. Arora S, Grewal P, Chand P,
Pharm. Pharmacol, 3: 327- 334, (2009). Dhillon V, Malik K, Goel A., A comparative
4. http://www.fda.gov/cder/guidance/index.htm bioequivalence study of some brands of
5. Indian Pharmacopeia., (3), 1169-70,(2007). Ofloxacin by urine and salivary analysis in
6. Koch-Wesser J., Serum drug concentrations india. IJDDR, 2 (3):534-546, (2010).
as therapeutic guides. N Engl J Med.,
287:227-31, (1982).
7. Lesne, M., Consideration on the
measurement of Bioavailability in man. Acta
Helv., 54 (1): 14–18, (1979).
8. Markham A, Faulds D., Theophylline A review
of its potential steroid sparing effects in
asthma. Drugs , 56:1081-91, (1998).